The PubChem BioAssay being used is a confirmatory assay called the Thermal Shift Assay, which aims to identify compounds that bind to the Kelch domain of the Keap1 protein. The assay is being measured in a Biochemical System using RT-PCR, specifically in the 2119-02 Inhibitor Dose CherryPick Activity. This is a direct single protein target assay that checks whether the identified compound is functional. The assay falls under the confirmatory category with Homo sapiens as the assay organism. Does the molecule exhibit efficacy in this assay?